Metrics as of 10/15/2026, 02:18 PM (Berlin time), refresh in progress.
Treace Medical Concepts Stock
Treace Medical Concepts, Inc.
Company data
- Sector
- Healthcare
- Industry
- Medical - Devices
- Country
- United States
- CEO
- John T. Treace
- Employees
- 450
- Market cap
- $263 M
- IPO
- 23/04/2021
Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty System, enables surgeons to correct all three dimensions of the bunion deformity, stabilize the first TMT joint, and allow return to weight-bearing in a…
Treace Medical Concepts stock: price history
1D
-1.5%
1W
+3.9%
1M
-12.7%
6M
+81.2%
YTD
+64.9%
1Y
-34.8%
2Y
-22.3%
5Y
-83.5%
10Y
–
Next earnings date
Next earnings date
05/11/2026 (in 19 days)
Volatility around earnings
~180% stronger price swings than usual
Ask the agents about Treace Medical Concepts
Analyst assessment of Treace Medical Concepts
PRICE TARGET LOW
US$3.00
CONSENSUS
US$8.60
MEDIAN
US$6.50
PRICE TARGET HIGH
US$16.00
0
STRONG BUY
2
BUY
6
HOLD
1
SELL
0
STRONG SELL
9
TOTAL · Hold
As of: 10/08/2026
Treace Medical Concepts stock metrics
P/E
-4.34
P/B
3.88
EV/EBITDA
-7.13
RETURN ON EQUITY
-23.4%
NET MARGIN
-35.0%
DEBT/EQUITY
1.07
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
73.5%
FLOAT SHARES
47,797,144
AVG. DAILY VOLUME (30D)
223,074
Insider transactions (SEC)
Elder Scot Michael
Treace John T.
Treace John T.
Treace John T.
Scanlan Sean F.
Institutional holders
Comparable stocks
Frequently asked questions about Treace Medical Concepts stock
What does Treace Medical Concepts do?
Treace Medical Concepts, Inc. is a company in the Healthcare sector, Medical - Devices industry, headquartered in United States.
The CEO is John T. Treace, the company employs around 450 people.
The IPO was on 23/04/2021; the stock trades on NASDAQ under the ticker TMCI.
What do analysts say about Treace Medical Concepts stock?
9 analysts rate the stock, the consensus is Hold (as of 10/08/2026).
The average price target is US$8.60, ranging from US$3.00 to US$16.00, with a median of US$6.50.
This is an external assessment, not a statement by Market Jury.
When does Treace Medical Concepts report next?
The next earnings date is 05/11/2026.
Around past earnings, price swings were roughly 180% stronger than usual.
Does Treace Medical Concepts pay a dividend?
No, Treace Medical Concepts currently does not pay a dividend.
Which stocks are comparable to Treace Medical Concepts?
Comparable stocks include Abbott Laboratories, Stryker, Boston Scientific, Edwards Lifesciences, DexCom, GE HealthCare Technologies, Zimmer Biomet Holdings and Align Technology.
How can I get Treace Medical Concepts stock analyzed?
Clicking "Analyze stock" lets five strategies assess Treace Medical Concepts against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.